VSNL1 Promotes Gastric Cancer Cell Proliferation and Migration by Regulating P2X3/P2Y2 Receptors and Is a Clinical Indicator of Poor Prognosis in Gastric Cancer Patients

Figure 4

Kaplan-Meier curves with univariate analyses (log-rank) for patients with low VSNL1 expression versus high VSNL1 expression. (a) Cumulative 5-year survival rates for patients with high VSNL1 expression were significantly lower than in patients with low VSNL1 expression. (b–d) According to the TNM stage, in stages I, II, and III, the patients with high expression of VSNL1 had a significantly lower 5-year survival rate than those with high expression (). (e) In stage IV, the expression of VSNL1 was not correlated with the 5-year survival rate ().

(a)

(b)

(c)

(d)

(e)